Before revision: Short-read sequencing methods Massively parallel signature sequencing (MPSS) The first of the high-throughput sequencing technologies, massively parallel signature sequencing (or MPSS ), was developed in the 1990s at Lynx Therapeutics, a company founded in 1992 by Sydney Brenner and Sam Eletr.
After revision: , also called next generation sequencingShort-read sequencing methods Massively parallel signature sequencing (MPSS) The first of the high-throughput sequencing technologies, massively parallel signature sequencing (or MPSS ), was developed in the 1990s at Lynx Therapeutics, a company founded in 1992 by Sydney Brenner and Sam Eletr.